Relationship Between Chronic Atrial Fibrillation and Worse Outcomes in Stroke Patients After Intravenous Thrombolysis
Author(s) -
Raymond C.S. Seet
Publication year - 2011
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneurol.2011.248
Subject(s) - medicine , modified rankin scale , atrial fibrillation , thrombolysis , stroke (engine) , odds ratio , incidence (geometry) , recombinant tissue plasminogen activator , cardiology , tissue plasminogen activator , ischemic stroke , ischemia , myocardial infarction , mechanical engineering , physics , optics , engineering
It is unclear whether stroke patients with atrial fibrillation (AF) are prone to adverse outcomes following treatment with intravenous recombinant tissue plasminogen activator, and whether the burden of AF affects these outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom